Carrier systems of radiopharmaceuticals and the application in cancer therapy.

Cell Death Discov · 2024 · PMC10776600 · PMID 38195680

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Recently, in the final analysis of overall survival and long-term safety of the phase III midgut NETs trial ( NCT01578239 ) [ 59 ], the median overall survival of the 177 Lu-DOTA-TATE group was 48.0 months and the control group was 36.3 months, which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.